Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL. Chris has been on the phone with the wrong people!
Not really. I suspect the hold had something to do with exclusion/inclusion criteria so maybe the FDA said, "well, what's done is done". It could have an effect on the trial outcome. The fact that Powers wont specify is still a red flag, imo.
The "Good" is that DCVax might, maybe, possibly, help cancer patients. The "Bad", from shareholders perspective, is a long long list.
Yeah, almost the price of a nice Benz. Lol
Hard to imagine, after Woodford's comments, any respectable fund manager would buy in. But you keep ignoring the elephant in the room...GOVERNANCE.
If true, strange that there'd be so little on social media or that the share price would be in the tank. Something just does not fit, imo.
...And this is also true. "Alternative facts"?
This is true. From the 10Q:
The trial is on partial clinical hold for screening of new patients for further enrollment; however, over 300 of the planned 348 patients are enrolled in the trial, and the patients already in the trial have continued to be treated in accordance with the trial protocol, without interruption. The Company is in ongoing dialog with regulators in regard to the partial hold.
Really? In case you did not notice shareholders are being diluted into oblivion EVEN with all the "great news". Powers appears to be just about out of cash again and another horrible deal may be on the way.
I don't see any official filing on that press release??
Nobody can deny it but it can be clarified, and i think Chinatown did a good job of it. Not a reason in the world Powers couldn't hold a cc for clarification.
Hundreds of post here and barely if any a mention of Woodford. I find that remarkable.
"Very clear" ...And you really don't think that had anything to do with Woodford or the SEC?
Doesn't pass the sniff test does it? But they're buying! Lol
...And if they get hit with the flu again say goodbye to that! Lol.
WHERE ARE THE BUYERS?
I'd bet just about every fund manager would likely have a chat with Woodford before dipping their toe in. But you people can ignore him and his importance to your detriment.
Here's how i think it went down:
Woodford, after publicly scolding NWBO on poor governance, puts a call into the SEC.
SEC begins an inquiry.
Powers forced into transparency request the FDA lift the halt since no more patients will be recruited anyway, and so issues this pr.
FDA complies.
I think that's where we are now. What's to come?
What about a reverse split, does she still need shareholder approval?
I'm sure Feuerstein will shine some light on this latest information. And let's not forget the SEC "inquiry". He seems to know something.
"For all we know, the FDA simply acknowledged the company decision to not pursue the final enrollment and therefore removed their ban from doing so. "
That's how i see it too.
Is the property in England part of the deal?
How many more shares outstanding and warrants now?
The past lousy volume and cash raise can tell you a lot. Big Pharma was not making offers. Why?
Woodford must force a board seat here to preserve his investment, imo.
No no no....You still don't get it. Sure there's plenty of good people involved but they don't care about shareholders. Powers should but...NWBO is out of money and more dilution sure to come. Reverse split in the air. DCVax may do some good eventually but CURRENT shareholders will likely not see a dime.
Funny, Woodford seems to feel mislead. I guess he wasn't really following though. Lol.
Correct. Take a look at Peregrine, CYTR, many others...All the same game plan.
What was weird?
Actually over the years I've found with boards like this expressing overwhelming positivity with just a few doubters, that the doubters are almost always right! ...I suppose it could have to do with pushing the doubters away too where the board is unbalanced??
Precisely. And people running these schemes aren't typically in the habit of giving money back. Enter the Reverse Split; Why waste all that fine talent and experience when they can do it again and again and again?
"I also applaud her resolute to see the trial to the very end to gain as much and as many data as possible in a blinded way. "
Yes, just as Woodford and his $100 plus million did. What if she's just collecting a nice salary and not really doing much at all (maybe lots more with Cognate?) except finding funds to for the university?
Actually that was a trick question! I think they'll be antother awful cash raise but we may never see results.
It's one thing to wait but it's an entirely other thing to wait while CEO, CFO, COB, Bookkeeper Powers, does horrendous cash raises. Think!
Of course it does. There's no excuse to exclude interim analysis. At the very least just for ongoing biomarker data.
Keep them in the dark while ever lower cash raises totals nice sums.
In these schemes it's the universities drawing in much need cash to conduct research via the "partner" sponsor's shareholders. So I fail to see how the university is the one being scammed??
As a possibility, what if the university isn't following trial protocol and tiny-under resourced-Northwest looks the the other way? You could imagine where this might lead and how shareholders would find themselves lost in the dark.
$30,000 of hot action so far this morning! Lol.
Would've made a nice PR, if it really meant anything. Too bad, I guess Powers is still down with the flu.
...Many sites show the DCVax study was last verified in 2014 so...
I bet that video is from 2013. There's a later 2016 video where she talks about Optune therapy. No mention of DCVax. You can tell by how she's talking the DCVax trial was over a while ago but she's only interested in the data.
Can't Toucan Capitaless step in the save them?
Well said, thank you.